Interestingly, ApoB100 is strongly associated with NAFLD in individuals with non-genotype 3 hepatitis C. In these cases, higher ApoB100 levels are significantly linked to a greater degree of liver steatosis, attributed to underlying insulin resistance [85]. This evidence concerns the gene APOB and metabolic dysfunction-associated steatotic liver disease.